MADISON ââ?¬â?? A new drug created by UW-Madison scientists in collaboration with Colby Pharmaceuticals may pave they way to successful prevention and treatment of prostate cancer. With a current lack of investment support for menââ?¬â?¢s health research, however, getting the drug to the critical clinical-trial phases remains a challenge.
Last month, Colby Pharmaceuticals wowed a panel of venture capitalists and angel investors at the Wisconsin Early Stage Symposium, earning a crown as one of the four winners of the ââ?¬Å?Elevator Pitch Olympics.ââ?¬Â For Colby’s breakthrough drug, called MDL, and three other drugs active against prostate cancer in the pipeline, this meant far more than simply a trophy or plaque.